Literature DB >> 8554477

Aerobic walking in slowly progressive neuromuscular disease: effect of a 12-week program.

N C Wright1, D D Kilmer, M A McCrory, S G Aitkens, B J Holcomb, E M Bernauer.   

Abstract

OBJECTIVE: Poor cardiorespiratory endurance is a common finding in neuromuscular disease (NMD), and the capacity of such patients to respond to aerobic training is unclear. This study was conducted to determine if a 12-week walking program results in increased aerobic capacity in slowly progressive NMD subjects, whether such a program is safely tolerated, and whether such patients can adhere to a self-monitored, home-based training program.
DESIGN: Before-after trial.
SETTING: Subjects' homes. PATIENTS: A cohort of 8 slowly progressive NMD subjects (4 men, 4 women) followed in the neuromuscular disease clinic participated (age, 36.6 +/- 8.0 yrs; ht, 170 +/- 11 cm; wt, 74.3 +/- 19.0 kg) (Mean +/- SD). INTERVENTION: Subjects walked 15 to 30 min 3 to 4 days a week at 50% to 60% of their heart rate reserve. MAIN OUTCOME MEASURES: Resting, submaximal, and peak heart rates, systolic and diastolic blood pressures, oxygen uptake, and peak power output.
RESULTS: Graded exercise testing to volitional fatigue using a semirecumbent cycle ergometer before and after the training program found significant decreases in submaximal heart rate by 7 +/- 3 beats/min (Mean +/- SEM) (95% CI = -23 to 9) (p = .046) and submaximal systolic blood pressure by 11 +/- 4 mmHg (95% CI = -31 to 9) (p = .019), and nonsignificant increases in peak power output and VO2.
CONCLUSIONS: These results suggest that moderate-intensity aerobic exercise training is well tolerated and may provide modest improvement in aerobic capacity in slowly progressive NMD subjects.

Entities:  

Mesh:

Year:  1996        PMID: 8554477     DOI: 10.1016/s0003-9993(96)90222-1

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  11 in total

1.  Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.

Authors:  Alexander Manta; Derek W Stouth; Donald Xhuti; Leon Chi; Irena A Rebalka; Jayne M Kalmar; Thomas J Hawke; Vladimir Ljubicic
Journal:  J Physiol       Date:  2019-01-30       Impact factor: 5.182

2.  Effect of treadmill exercise on serotonin immunoreactivity in medullary raphe nuclei and spinal cord following sciatic nerve transection in rats.

Authors:  Arthiese Korb; Leandro Viçosa Bonetti; Sandro Antunes da Silva; Simone Marcuzzo; Jocemar Ilha; Mariane Bertagnolli; Wania Aparecida Partata; Maria Cristina Faccioni-Heuser
Journal:  Neurochem Res       Date:  2009-09-23       Impact factor: 3.996

3.  Childhood Activity on Progression in Limb Girdle Muscular Dystrophy 2I.

Authors:  Brianna N Brun; Shelley R H Mockler; Katie M Laubscher; Carrie M Stephan; Julia A Collison; M Bridget Zimmerman; Katherine D Mathews
Journal:  J Child Neurol       Date:  2016-11-22       Impact factor: 1.987

Review 4.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

5.  A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy.

Authors:  R C Graham; R A C Hughes; C M White
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

Review 6.  Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders.

Authors:  Julia Rebecka Dahlqvist; John Vissing
Journal:  J Mol Neurosci       Date:  2015-11-19       Impact factor: 3.444

7.  Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes.

Authors:  Andrew I Mikhail; Peter L Nagy; Katherine Manta; Nicholas Rouse; Alexander Manta; Sean Y Ng; Michael F Nagy; Paul Smith; Jian-Qiang Lu; Joshua P Nederveen; Vladimir Ljubicic; Mark A Tarnopolsky
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

8.  Amount and intensity of daily living activities in Charcot-Marie-Tooth 1A patients.

Authors:  Federica Menotti; Luca Laudani; Antonello Damiani; Andrea Macaluso
Journal:  Brain Behav       Date:  2013-10-30       Impact factor: 2.708

9.  Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial.

Authors:  Landry-Cyrille Bankolé; Guillaume Y Millet; John Temesi; Damien Bachasson; Marion Ravelojaona; Bernard Wuyam; Samuel Verges; Elodie Ponsot; Jean-Christophe Antoine; Fawzi Kadi; Léonard Féasson
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Aerobic anti-gravity exercise in patients with Charcot-Marie-Tooth disease types 1A and X: A pilot study.

Authors:  Kirsten L Knak; Linda K Andersen; John Vissing
Journal:  Brain Behav       Date:  2017-11-02       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.